MK-677 in Thailand: Growth Hormone Secretagogue Therapy
MK-677 (Ibutamoren) is an orally active growth hormone secretagogue that stimulates sustained GH and IGF-1 release through ghrelin receptor activation, supporting muscle recovery, bone density, deep sleep quality, and body composition improvement. It is prescribed in physician-supervised protocols for recovery enhancement, longevity support, and age-related GH decline.
Doctor-prescribed MK-677 in Thailand is available at Peptides Thailand under physician supervision, with clinical-grade, COA-verified oral capsules. It is prescribed for growth hormone optimization protocols requiring daily oral dosing, most frequently for body composition improvement, recovery support, and sleep quality.
How MK-677 Works
MK-677 operates through sophisticated pathways to enhance growth hormone secretion. Its primary mechanism involves mimicking ghrelin and binding to the GH secretagogue receptor (GHSR), stimulating natural growth hormone release. The compound also demonstrates significant effects on IGF-1 levels and metabolic function through multiple molecular pathways.
Medical Review Status
Last reviewed: June 2026 | Next review: December 2026
Written by Dr. Michael Ackland · Medically reviewed by Dr. Ploy Pitayanon, MD, licensed by the Medical Council of Thailand
At a Glance
Peptide
MK-677
Category
Oral Peptide
Dosage
25mg
Frequency
1 capsule daily on empty stomach
Administration
Oral capsules
Potential Benefits
- · Enhances muscle recovery
- · Promotes lean mass gains
- · Improves sleep quality
Quality Matters
Why we use Clinical-Grade only
Certificate of Analysis
Every peptide we dispense comes with a third-party COA confirming purity and potency, never grey-market sourced.
Compounded in Thailand
Manufactured in Thai FDA-licensed compounding laboratories operating under GMP standards.
Physician-prescribed only
No dispensing without a prescription. Every protocol begins with a licensed physician consultation and clinical assessment.
Medical Disclaimer
The information on this page is intended for educational and informational purposes only and should not be considered medical advice, diagnosis, or treatment. Any therapies, consultations, or prescriptions are provided only following assessment by a licensed physician and where clinically appropriate. Individual results may vary and no specific outcomes are guaranteed. Certain compounds discussed may not be approved medicines registered with the Thai FDA for specific therapeutic indications. Nothing here should be interpreted as a recommendation to self diagnose, self treat, or replace consultation with a qualified healthcare professional.
Doctor's Note
Dr. Ploy Pitayanon, MD, Medical Lead
MK-677 requires careful medical supervision and individualized dosing. Our clinics in Chiang Mai and Phuket provide comprehensive assessment, monitoring, and ongoing support to ensure safe and effective treatment outcomes.
Potential Benefits
Enhances muscle recovery
Promotes lean mass gains
Improves sleep quality
Supports bone density
Enhances healing processes
Improves skin health
Supports fat metabolism
Increases strength
Enhances recovery
Promotes anabolism
Speak with a physician
Interested in MK-677?
All protocols require a physician assessment before any prescription is issued. Book a free video consultation with an MCT-licensed doctor.
Treatment Protocol
Dosage
25mg
Frequency
1 capsule daily on empty stomach
Duration
12-16 weeks
Administration
Oral capsules
Safety guide
MK-677 Side Effects & Safety
Frequency, contraindications, and who is a good candidate
Recent MK-677 Research
Effects of Oral Administration of Ibutamoren Mesylate (MK-0677) on GH Secretion in Healthy Adults
Demonstrated oral MK-0677 (ibutamoren) significantly increased GH and IGF-1 levels in healthy adults via GHSR-1a agonism, confirming its efficacy as a once-daily oral GH secretagogue (Clin Pharmacol Ther, 2001).
View on PubMedThe Effects of MK-0677, an Oral GH Secretagogue, in Patients with Hip Fracture
Showed MK-0677 improved functional recovery markers and muscle mass in elderly hip fracture patients, demonstrating clinical utility of GH secretagogues for sarcopenia and recovery (J Am Geriatr Soc, 2004).
View on PubMedGrowth Hormone Secretagogue MK-677: No Clinical Effect on Alzheimer's Disease Progression
Conducted a randomised trial of MK-677 in Alzheimer's patients, documenting its pharmacokinetic profile and GH/IGF-1 elevating effects while providing clinical safety and tolerability data at therapeutic doses (Neurology, 2008).
View on PubMedRelated Peptides
Prefer to message first?
Chat with our team on WhatsApp. We typically reply within minutes.
Chat about MK-677